Has Fouad Azoury, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,454 in general payments to Fouad Azoury, MD across 262 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fouad Azoury, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fouad Azoury, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fouad Azoury, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Detroit, MINPI 1265735047

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 262 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Medtronic at 43.9% of the total.

$20,454in general payments, 2019–2025

Across 262 payments — averaging $78.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$9K
Edwards Lifesciences$3K
Atricure, Inc.$3K
Abiomed$2K
Abbott$1K
Boston Scientific$390
plus $2K from 17 others

What the payments were for

Travel & lodging$410%
Food & beverage$20,27499%
Education$310%
Entertainment$1081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	118	$8,985
Edwards Lifesciences	59	$3,308
Atricure, Inc.	21	$2,875
Abiomed	14	$1,726
Abbott	11	$1,094
Boston Scientific	5	$390
Artivion, Inc.	2	$334
Chiesi USA, Inc.	10	$252
Shockwave Medical, Inc	1	$182
Recor Medical Inc	1	$170
Getinge USA Sales, LLC	3	$156
Terumo Cardiovascular Systems Corporation	2	$144
Teleflex LLC	2	$141
Inari Medical, Inc.	1	$133
La Jolla Pharmaceutical Company	1	$115
Bard Access Systems, Inc.	1	$109
Philips North America LLC	1	$108
Baxter Healthcare	3	$80
Davol Inc.	2	$53
LSI Solutions Inc	1	$34
Kestra Medical Technology Services, Inc.	1	$22
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$20
Zimmer Biomet	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,454 in reported general payments places this provider in the 80th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan →

Medicare billing

Part B allowed, 2024

$103,987

Medicare patients

Services billed

186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mupirocin	11	$62

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Detroit

Raed AlnajjarDetroit$781K
Zane HammoudDetroit$208K
Sanjay BatraDetroit$84K
Kyle MileticDetroit$22K
Hassan NemehDetroit$22K
Omar HabibDetroit$20K
Steven BollingAnn Arbor$41.7M
Gorav AilawadiAnn Arbor$434K
Reza DabirDearborn$342K
Shinichi FukuharaAnn Arbor$236K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →